The Centers for Disease Control and Prevention has awarded a $1.4 million grant to a University of Albany professor, Melonie ...

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark ... Injectable Cabotegravir for HIV Prevention Is Safe in Pregnancy, Study ...

December is HIV/AIDS ... White HIV/AIDS Program to provide services for underserved populations with HIV/AIDS. The long-term goal in the U.S. is to end the HIV epidemic through prevention and ...

These artworks and the posters carry the real feelings of people living with HIV and the voices of the artists to inspire ... director of the Chinese Association of STD and AIDS Prevention and Control ...

“The de-prioritization of HIV prevention is among the top sustainability threats,” said Thembisile Xulu, Chief Executive Officer of the South African National AIDS Council. While prevention will ...

A rash may occur after you contract HIV. It commonly appears on the face and chest but can also appear in other places. Medications used to treat HIV as well as certain infections may also cause ...

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world ... head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria.

A $1.5 million grant given to the Harlem United Community Aids Center in New York City ... by the federal dollars through the provision of HIV prevention services. President Joe Biden speaks ...

However, this week at last looks set to be all about the Man of Tomorrow as the first poster for the movie has just been released by DC Studios. Shared as both a motion poster and traditional ...

The first official poster for James Gunn's Superman is here - and the first official trailer is arriving later this week. Gunn took to Instagram to share the moving poster, which sees David ...

While the efficacy of twice-yearly subcutaneous lenacapavir for HIV prevention has previously been demonstrated in cisgender women, its efficacy for PrEP in cisgender men, transgender women, ...